Ajit Lalvani, professor at Imperial College of London, discusses the school’s report that found high-levels of protective immune cells that fight some common colds can also make people less likely to contract covid. He speaks on “Bloomberg Markets: Europe.”
Pfizer Inc.’s vaccine provides less immunity to the omicron variant than to other major versions of Covid-19, according to laboratory experiments that still indicated a third dose may help stop the highly mutated strain. Bloomberg Intelligence’s Sam Fazeli has the…
Johns Hopkins University Associate Professor of Emergency Medicine Bhakti Hansoti discusses the evolution of Covid-19 and global surges of the virus. The Bloomberg School of Public Health is supported by Michael R. Bloomberg, founder and majority owner of Bloomberg LP,…
Mixing Covid vaccines produces as much or more antibodies as using the same shot as a booster, according to preliminary results of a widely awaited U.S. government-sponsored trial. Today, FDA advisers begin meeting to debate whether people who got the Covid-19 vaccines…
Sep.14 — Dr. Amesh Adalja, Johns Hopkins Center for Health Security senior scholar, discuses lockdown measures in New Zealand and debate over Covid-19 vaccine booster shots. The Johns Hopkins Bloomberg School of Public Health is supported by Michael R. Bloomberg,…
Aug.30 — Johns Hopkins Bloomberg School of Public Health Vice Dean Joshua Sharfstein discusses Covid-19 in children, how schools deal with virus outbreaks, and vaccine production with the use of booster shots in the U.S. The Bloomberg School of Public…
